C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

C4 Therapeutics had revenue of $8.47M in the quarter ending September 30, 2026, a decrease of -24.59%. This brings the company's total for the last twelve months to $32.28M, up 7.20% year-over-year. In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. That makes C4 Therapeutics the 30,914th largest company in the world by revenue and 4,074th in the United States.

• Revenue (ttm): $32.28M
• Revenue Growth: +7.20%
• P/S Ratio: 11.23
• Revenue / Employee: $310,356
• Employees: 104
• Market Cap: 362.44M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.95M	363.00K	1.02%
Dec 31, 2024	35.58M	4.49M	14.43%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%
Dec 31, 2019	21.38M	2.02M	10.42%
Dec 31, 2018	19.36M	-	-

Data Source: Fiscal.ai Last updated: Nov 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error